close solid momentum fortifi confid outlook core
revenu growth acceler key pillar outperform thesi see multipl sourc
top bottom line upsid potenti rel reiter seemingli conserv
guidanc multipl robust said view relative/fundament downsid
risk limit price target
revenu beat consensu forecast
key driver revenu beat life scienc beat vs cowen vs
consensu follow diagnost beat vs cowen vs consensu
ea beat vs cowen vs consensu dental revenu roughli line
report basi light core growth basi overal core revenu growth
like exceed consensu expect
ebita margin expand y/i forecast gaap
oper margin forecast consensu
importantli opportunist oper reinvest ep
y/i beat consensu forecast ep beat larg driven
revenu margin upsid
core revenu growth adjust ep guid
respect line expect ep guidanc
reiter think reflect pragmat conservat given still earli year
increas full year report revenu growth estim
reflect favor fx environ contribut core
also lower full year tax rate estim increas
share count estim total increas ep estim reflect
aforement item ep estim high end guidanc
larg due fx tax see sourc potenti upsid
appeci sinc call trade healthi multipl
ebitda ep said see mani upcom potenti
neg catalyst see multipl driver revenu ep upsid fx core
execut also like capac
drive materi upsid estim said even deploy free
cash flow could still drive ebitda upsid given view healthi
end market outlook upsid remain outperform increas
price target base ebitda slight discount peer discount
assum conserv contribut dcf analysi
pleas see page report import disclosur
believ well posit progress improv core revenu growth
beyond addit believ least capac
next month could result a-driven ep upsid dcf multipl
analysi support price target improv growth margin could take
ep upsid year
ep upsid year
capit deploy drive ep
diversifi multi-industri compani signific presenc health care
environment test manufactur market becom focus
health care compani spin-off juli sale gener
life scienc diagnost dental market danah histor success larg
function strong manag team danah busi system db
compani report thomson eikon cowen compani
cowen vs consensu mm except core growth fx full year dec core growthgross dec revenu metric mm except growth constant currenc organ growth constant currenc organ growth constant currenc organ environ appli growth constant currenc organ incom statement mm except growth currenc growth growth rate incom count margin expand y/i forecast oper margin forecast consensu note dental core oper margin declin y/i off-set strong margin perform life scienc diagnost tax rate ep beat consensu forecast beat larg driven revenu margin upsid consensu ea revenu beat forecast consensu growth better forecast commentari across major busi qualiti product id posit streetaccount consensu life scienc revenu beat forecast consensu growth beat forecast almost manag note pall particular strong quarter pall life scienc dd pall industri msd importantli appear growth came expens believ much solid growth attribut improv underli demand life scienc core oper margin expand impress y/i streetaccount consensu diagnost revenu beat forecast consensu growth beat forecast almost manag note cepheid particular strong quarter y/i growth believ part driven moder sever flu season diagnost check suggest flu assay low stock streetaccount consensu dental revenu came million light consensu forecast growth forecast note time preview bia rel forecast like downsid given distributor realign equip sale accordingli surpris result revenu beat consensu forecast key driver revenu beat life scienc follow diagnost ea dental revenu roughli line report basi pall y/i growth cepheid y/i growth strong quarter though busi includ sciex msd beckman life scienc hsd ea msd also solid growth revenu growth like exceed consensu expect gross margin line forecast expens percentag revenu line forecast sg expens percentag revenu forecast cowen
compani report cowen compani
mm except yr core growth growth core growth reiter constant currenc exchang growth currenc total exchang growth currenc like contribut growth legaci dx total exchang growth currenc total exchang appli growth currenc total exchang cowen
compani report thomson eikon cowen compani
mm except yr cagrcommentsnet core growth core growth reiter constant gener cost synergi total oper target expansion/yearincrement pall cost synergi non-oper interest adjust could closer tax reform net share count full yearnon-gaap jan consensu except gross op cowen
price target base sever methodolog may includ analysi market risk
group ev/ebitda premium discount averag group price-to-earnings sum part net asset
valu dividend return return equiti roe next month
risk medic life scienc tool sector may includ reduct delay research
develop budget govern fund reduc delay purchas
health care hospit custom increas extend regulatori hurdl process
regul product increas depend volatil emerg market revenu
profit gener macroeconom challeng
make invest recommend earli stage pre-commerci ls dt
compani base upon assess technolog probabl market success
competit regulatori reimburs etc potenti market opportun
event success howev compani lack tradit and/or matur
financi metric believ good methodolog assign specif
target price stock
downsid risk includ limit macroeconom deterior
current level inabl execut integr eros market share price
due competit inabl deliv margin target value-destruct
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock danah corpor thermo fisher scientif secur
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
avenu floor new york ny addit import disclosur except valuat method risk avail firm disclosur
websit http //cowen bluematrix com/sellside/disclosur action
equiti research price target cowen compani llc assign price target compani cover equiti research unless note otherwis equiti research price target
issuer stock repres valu analyst reason expect stock reach perform period twelv month price target equiti secur
report consid context prior publish cowen compani llc equiti research report includ disclosur equiti report
firm disclosur websit may may includ equiti research price target well develop relat issuer industri financi market
equiti research price target valuat methodolog risk associ achiev given equiti research price target pleas see analyst equiti research report
publish target
cowen credit research trade due natur fix incom market issuer debt secur issuer discuss cowen credit research trade
research report assign rate price target may continu follow accordingli investor must regard brand report provid stand-alon
analysi reflect analyst opinion date report expect continu analysi addit report relat issuer debt secur
time time cowen credit research trade research analyst provid invest recommend secur subject report
recommend intend time date public within paramet specifi individu report cowen credit research trade
invest recommend made strictli case-by-cas basi recommend provid part overarch rate system set consist
appli benchmark view express report may differ view offer firm equiti research report prepar client
notic uk investor public produc cowen compani llc regul unit state finra commun person kind
describ articl servic market act promot order must transmit person without
notic european union investor individu produc recommend requir obtain certain licens financi regulatori author finra review
author current licens statu histori employ histori report regulatori custom disput crimin matter via brokercheck finra http //
brokercheck finra org/ individu licens statu finra constru endors finra gener biograph inform also avail
research analyst www cowen com
addit complet preced recommend histori relat recommend research report avail http //cowen bluematrix com/sellside/
recommend contain report produc januari et dissemin januari et
copyright user agreement gener inform relat report
cowen compani llc right reserv member nyse finra sipc research report prepar exclus use cowen client may
reproduc display modifi distribut transmit disclos whole part form manner other outsid organ without express prior
written consent cowen cowen research report distribut simultan client elig receiv research report unauthor use disclosur
